Manufacturers/Validus Pharmaceuticals LLC

Validus Pharmaceuticals LLC

8 drugs in NADAC|0 Generic,8 Brand

Validus Pharmaceuticals LLC lists 8 NDCs in the CMS NADAC file (0 generic, 8 brand), at an average NADAC of $2.56 per unit, with a week-over-week move of -0.2% across products that moved. The firm's full portfolio, pricing trend are listed below.

Total Drugs

8

0G / 8B

Avg Price / Unit

$2.5623

$0.75 – $4.70

Avg 7d Change

-0.18%

Across 5 drugs with changes

7d Activity

53 flat

of 8 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Frequently Asked Questions

How many drugs does Validus Pharmaceuticals LLC make?

Validus Pharmaceuticals LLC lists 8 NDCs in the CMS NADAC file — 0 generic and 8 brand products.

What is the average price of Validus Pharmaceuticals LLC drugs?

The average NADAC across Validus Pharmaceuticals LLC's portfolio is $2.5623 per unit, ranging from $0.7487 to $4.6997.

What types of drugs does Validus Pharmaceuticals LLC make?

Validus Pharmaceuticals LLC makes drugs across 4 FDA pharmacologic classes. The most common by NDC count are Mood Stabilizer (3), Loop Diuretic (3), Serotonin Reuptake Inhibitor (1), beta-Adrenergic Blocker (1).

Has Validus Pharmaceuticals LLC had any drug recalls?

No FDA enforcement recalls are matched to Validus Pharmaceuticals LLC in the openFDA feed.

How has Validus Pharmaceuticals LLC's pricing changed recently?

Over the past 7 days, 0 Validus Pharmaceuticals LLC products rose and 5 fell, with a portfolio-wide average change of -0.2%.

Drug Portfolio

8 drugs total, 8 shown

Drug Price 7d Change
EQUETRO 300 MG CAPSULE
Carbamazepine
$4.6997
per EA
EQUETRO 200 MG CAPSULE
Carbamazepine
$4.1677
per EA
-0.36%
EQUETRO 100 MG CAPSULE
Carbamazepine
$3.6545
per EA
-0.13%
RALDESY 10 MG/ML SOLUTION
TRAZODONE HYDROCHLORIDE ORAL
$2.4544
per ML
-0.18%
LOPRESSOR 50 MG TABLET
metoprolol tartrate
$2.4163
per EA
LASIX 80 MG TABLET
FUROSEMIDE
$1.3060
per EA
LASIX 40 MG TABLET
FUROSEMIDE
$1.0512
per EA
-0.10%
LASIX 20 MG TABLET
FUROSEMIDE
$0.7487
per EA
-0.11%